Researchers have established a causal link between the chemokine CXCL9 and accelerated epigenetic aging, as measured by the GrimAge clock, in a recent study published in Cell Genomics. This study highlights how inflammaging, characterized by chronic systemic inflammation, is intricately connected to epigenetic aging processes. The findings indicate that older individuals exhibit increased levels of CXCL9, which correlates with both faster epigenetic aging and a higher likelihood of mortality, emphasizing the role of inflammation in age-related decline.

The significance of this research lies in its elucidation of the relationship between inflammatory biomarkers and epigenetic aging clocks. Using data from the BCG-PRIME cohort, the study found that frailty and multimorbidity were strongly associated with GrimAge, while other epigenetic clocks like PhenoAge also demonstrated notable connections to inflammatory markers. Notably, CXCL9 and tumor necrosis factor (TNF) emerged as key players, with the study confirming their causal roles in accelerating epigenetic aging. This suggests that targeting these inflammatory pathways could present therapeutic opportunities for mitigating age-related diseases.

The implications of this work are profound for the field of aging research. By establishing CXCL9 as a potential biomarker for epigenetic aging, this study shifts the focus toward the interferon pathway and its role in aging. Future research could explore whether interventions aimed at reducing CXCL9 levels or modulating the inflammatory response could effectively slow down epigenetic aging and improve healthspan. This could accelerate drug development timelines for therapies targeting chronic inflammation in aging populations, ultimately enhancing longevity and quality of life.

Source: lifespan.io